GSK takes 10% stake in CureVac for £130m in collaboration deal
20th Jul 2020 06:56
(Sharecast News) - GlaxoSmithKline said it would invest £130m to take a 10% stake in Germany's CureVac and collaborate to develop up to five mRNA-based vaccines and antibodies to fight infectious diseases.
Read moreWednesday broker round-up
15th Jul 2020 12:24
(Sharecast News) - Royal Dutch Shell: JP Morgan downgrades to neutral with a target price of 1,700.0p.
Read moreGlaxoSmithKline myeloma treatment gets nod from FDA committee
15th Jul 2020 07:30
(Sharecast News) - GlaxoSmithKline announced on Wednesday that the oncologic drugs advisory committee of the US Food and Drug Administration (FDA) has voted in favour of "the demonstrated benefit" of monotherapy treatment with 'belantamab mafodotin'.
Read moreMorgan Stanley sees cycle turning higher for 'value' stocks
13th Jul 2020 13:55
(Sharecast News) - Equity strategists at Morgan Stanley sounded a positive note on so-called 'value' stocks, arguing that the economic cycle was shifting into a 'recovery regime' - but there was catch.
Read moreJP Morgan says 'pent-up' demand will be exhausted, stays 'overweight' on Tech and Healthcare
13th Jul 2020 12:48
(Sharecast News) - Equity strategists at JP Morgan believe that second quarter corporate results on both sides of the Atlantic may come in ahead of analysts' forecasts, helped by the fact that estimates were at very depressed levels.
Read moreGSK partners with Canada's Medicago to develop plant-based Covid-19 vaccine
7th Jul 2020 16:59
(Sharecast News) - GlaxoSmithKline has teamed up with Canada's Medicago to develop a vaccine which its hopes will be ready for use in the first half of 2021.
Read moreSunday newspaper round-up: Vouchers, Grocers, Boohoo
5th Jul 2020 15:59
(Sharecast News) - Radical plans to give all adults £500 and children £250 in vouchers to spend in sectors of the economy worst hit by the Covid-19 crisis are being considered by the Treasury. The proposals, drawn up by the Resolution Foundation think tank, which has had recent talks with the Treasury about its ideas, are aimed at kickstarting economic recovery by triggering a highly targeted surge in spending. Under the plans the vouchers could only be spent in certain sectors, such as hospitality and "face to face" retail, as opposed to online. - Guardian
Read moreInovio Pharmaceuticals's Covid-19 vaccine triggers immune response
30th Jun 2020 18:34
(Sharecast News) - Inovio Pharmaceuticals's experimental vaccine against the novel coronavirus was found to be safe in an early stage clinical trial and successfully induced an immune response in the majority of participants in the test.
Read moreSingle course of Covid-19 treatment to cost $2,340 per patient - Gilead
29th Jun 2020 12:00
(Sharecast News) - Gilead Sciences has announced it will charge developed countries $390 a vial for remdesivir, its antiviral drug currently being investigated for use in Covid-19 patients.
Read moreGlaxoSmithKline clears regulatory hurdle in Japan for 'Duvroq'
29th Jun 2020 08:28
(Sharecast News) - GlaxoSmithKline announced the approval of a Japanese New Drug Application (JNDA) by the Ministry of Health, Labour and Welfare in that country on Monday, for 'Duvroq', or daprodustat tablets.
Read moreAntibody levels of Covid-19 patients decline quickly, small study shows
22nd Jun 2020 12:54
(Sharecast News) - Levels of antibodies in people who have suffered Covid-19 reportedly falls sharply in the two to three months following their infection, a study showed, although the implications for patient immunity were unclear.
Read moreBerlin invests 300.0m euro in Covid-19 maker CureVac
15th Jun 2020 12:07
(Sharecast News) - Berlin unveiled a multi-million dollar investment into German biotechnology outfit CureVac, alongside dievini Hopp BioTech, SAP co-founder Dietmar Hopp's holding company.
Read moreSunday newspaper round-up: Two meters, Rolls Royce, Clinigen
14th Jun 2020 19:22
(Sharecast News) - Senior scientists have reported flaws in an influential World Health Organization-commissioned study into the risks of coronavirus infection and say it should not be used as evidence for relaxing the UK's 2-metre physical distancing rule. Critics of the distancing advice, which states that people should keep at least 2 metres apart, believe it is too cautious. They seized on the research commissioned by the WHO, which suggested a reduction from 2 metres to 1 would raise infection risk only marginally, from 1.3% to 2.6%. - Guardian
Read moreGSK to produce 1bn doses of vaccine boosters
28th May 2020 11:06
(Sharecast News) - Pharmaceutical company GlaxoSmithKline announced it will produce 1bn doses of coronavirus vaccine booster in preparation for an eventual immunisation drive.
Read moreSanofi to sell stake in Covid-19 treatment maker Regeneron
26th May 2020 11:59
(Sharecast News) - Sanofi will sell its stake in US-based maker of Covid-19 treatments Regeneron Pharmaceuticals.
Read more